The blog is what it felt like. This is what the numbers show: real-world evidence from thousands of patient reports, side-by-side drug comparisons, and plain-language reference material on GLP-1 medications and peptides. Technical, sourced, and never medical advice.
We analyzed 14,252 Reddit posts about retatrutide, tirzepatide, and semaglutide -- side effects, severity, remedies, benefits, and switching patterns. Every data point links to the original thread.
Filter by drug, side effect, severity, and remedies -- including a women-specific view of 4,651 reports.
The full findings in one downloadable report. Published on Zenodo (DOI: 10.5281/zenodo.18943922).
Clinical trial data next to what patients actually report. Updated as the dataset grows.
The triple agonist against Zepbound/Mounjaro: efficacy, side effects, and switching patterns.
How retatrutide compares to Ozempic/Wegovy in trials and real-world reports.
The two approved heavyweights, head to head on weight loss and tolerability.
Plain-language technical explainers on the peptides and blends people ask about.
Step by step with a full video: how much bacteriostatic water, mixing, syringe units, storage, and why a 10 mg and 40 mg vial look identical.
The mitochondrial peptide: what the research shows, the exercise finding people get backwards, and its 2026 FDA and WADA status. Reference, not medical advice.
The four-peptide blend (GHK-Cu, BPC-157, TB-500, KPV): what's in it, why recipes vary, and where each component stands with regulators.
The recovery peptide: what the preclinical research actually shows, its 2026 FDA status, and how it appears in blends. Reference, not medical advice.
WeightSnap